Organization
Biogen, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Biogen, Inc.
... Cambridge - Biogen Inc. (NASDAQ: BIIB) announced today that it will present at the UBS ...
... includeGeorge Vradenburg- Chairman, UsAgainstAlzheimer's;Ivana Rubino- Global Head of Medical, Alzheimer's Disease at Biogen;Leigh Callahan- Caregiver and Professor of Medicine and Associate Director at the UNC ...
... genes. In 1978, Sharp was a cofounder of the Cambridge biotech company Biogen, and the dinner was held to mark its incredibly improbable 40th birthday. ...
... either based in Massachusetts or with significant operations here, including pharmaceutical giants Biogen and Shire. Biogen was reported to the FDA by a generic-producing company ...
... the scientific underpinnings of the medicine for more than 15 years. Now Biogen Inc., the Cambridge biotech that shepherded it to approval, could start selling ...
... a CNBC report, ­every 33 seconds, someone in the US develops Alzheimer's. Biogen is testing Aducanumab, a drug that shows promise in treating Alzheimer's. However, ...
... for the treatment of inflammatory and neurological indications. The Company granted to Biogen an irrevocable license to all of its IP through the recent Settlement ...
... executed our commercialization strategy through the expansion of our strategic relationship with Biogen in neurological diseases and our commercialization of inotersen through our affiliate, Akcea. ...
... for the treatment of inflammatory and neurological indications. The Company granted to Biogen an irrevocable license to all of its IP through the recent Settlement ...
Subscribe now for full coverage on Biogen, Inc.
Start My Free Trial